MERILISA HIV 1-2 GEN 3
Merilisa HIV 1-2 Gen 3rd is an enzyme immunoassay for the qualitative determination of antibodies to Human Immunodeficiency virus HIV-1 and HIV-2 in human serum or plasma. Merilisa HIV 1-2 Gen 3rd is intended to detect IgG, IgM and additionally IgA to the envelope glycoproteins of HIV-1 and HIV-2 using recombinant proteins gp41, gp120 and gp36.
- 3rd Generation Antibody capture Sandwich ELISA
- Use of Highly purifoed recombinant antigen
- Increased standardization, test robustness and reproducibility
- Convenient microwell sample dilution
Benefits
01
Detection of IgM reduces the window period
02
Detects subtype 'O' and 'C'
03
Diagnostic Sensitivity : 100%
04
Diagnostic Specificity : > 99.5%
Indications
- Merilisa HIV 1-2 Gen 3rd is intended to detect IgG, IgM and additionally IgA to the envelope glycoproteins of HIV-1 and HIV-2 using recombinant proteins gp41, gp120 and gp36
Product Specifications
| Intended Use | 3rd Generation based immunoassay for qualitative determination of antibodies against HIV 1 and HIV 2 |
| Principle | Sandwich Immunoassay |
| Technique | ELISA |
| Detection | Antibodies to HIV -1 and HIV -2 (IgM, IgG and IgA) |
| Capture | gp 41 and gp 120 for HIV -1; gp 36 for HIV -2 |
| Conjugate | Recombinant antigens (gp 41, gp 36 and gp 120) conjugated with Horse Radish Peroxidase |
| Type of Specimen required | Serum or Plasma |
| Total incubation time | 90 minutes |
| Diagnostic Sensitivity | 100% |
| Diagnostic Specificity | > 99.5% |
| Evaluation | National Institute of Biologicals |
Ordering Information
| Product Code | Material Description | Pack Size |
|---|---|---|
| HV3ELI-01 | Merilisa HIV 1-2 Gen 3rd | 96 Wells |
Clinical Data
Product IFU
Note: IFU will be displayed after MDR Certification